Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Erythrocytes, commonly known as red blood cells (RBCs), are the most abundant type of blood cell in vertebrates and serve as the principal means of delivering oxygen from the lungs to body tissues via the circulatory system. They also transport carbon dioxide, a waste product, from tissues back to the lungs for exhalation. Erythrocytes are biconcave discs, lacking a nucleus and organelles, and are filled with hemoglobin, which binds oxygen. They are produced in the red bone marrow and have a lifespan of approximately 100–120 days.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Erythrocyte (RBC).